Back to Archived Journals » Comparative Effectiveness Research
Comparative Effectiveness Research ceased publishing in September 2018. All articles that have been published in Comparative Effectiveness Research will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Comparative Effectiveness Research
ISSN: 1179-8483
- View all (32)
- Volume 8, 2018 (3)
- Volume 7, 2017 (1)
- Volume 6, 2016 (3)
- Volume 5, 2015 (8)
- Volume 4, 2014 (3)
- Volume 3, 2013 (4)
- Volume 2, 2012 (4)
- Volume 1, 2011 (6)
Journal Articles:
- 32 records -
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Local triamcinolone acetonide injection for treatment of nasal tip cysts
![](cr_data/cache/submission_images/s150000/150748/27_apr_2018_150748_fig1_200_200_90.jpg)
Li Z, Wang M, Zhang L, Zhang N, Xiang N, Fu ZQ
Comparative Effectiveness Research 2018, 8:19-21
Published Date: 27 April 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Application of an adapted PRECIS-2 instrument to assess efficacy- and effectiveness-study designs in a systematic review of intervention studies of the hepatitis C virus-care continuum among people who use drugs
Jordan AE, Perlman DC, Smith DJ, Hagan H
Comparative Effectiveness Research 2018, 8:3-17
Published Date: 4 April 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]
Li J, Ren HY, Zhang J, Dong P, Wang Y, Stevens AL, Han Y, Huang M
Comparative Effectiveness Research 2018, 8:1-2
Published Date: 24 January 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China
Li J, Ren HY, Zhang J, Dong P, Wang Y, Stevens AL, Han Y, Huang M
Comparative Effectiveness Research 2017, 7:1-9
Published Date: 23 January 2017
![Noteworthy comment: It is important to note that one essential aspect of translational effectiveness in general, and comparative effectiveness research in particular is the charge and the ability of all in the field to describe clearly what the process is, for what fundamental reason it is preformed to way it is, and to disseminate comparative effectiveness research to stakeholders. In order to do that, we must strive to engage specialists as well as the non-expert readership with the key take-always from our research findings in non technical terms. This what these authors have done so well here.Therefore, we applaud this noteworthy publication.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evidence-based research: understanding the best estimate
Bauer JG, Spackman SS, Fritz R, Bains AK, Jetton-Rangel J
Comparative Effectiveness Research 2016, 6:23-31
Published Date: 7 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Matching-adjusted indirect treatment comparison in patients with radioiodine-refractory differentiated thyroid cancer
Tremblay G, Holbrook T, Milligan G, Pelletier CL, Rietschel P
Comparative Effectiveness Research 2016, 6:13-21
Published Date: 20 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Esophageal cancer: comparative effectiveness of treatment options
Xu C, Lin SH
Comparative Effectiveness Research 2016, 6:1-12
Published Date: 13 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Off-pump versus on-pump coronary artery bypass grafting: comparative effectiveness
Raja SG
Comparative Effectiveness Research 2015, 5:73-79
Published Date: 4 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Implementation of comparative effectiveness research in personalized medicine applications in oncology: current and future perspectives
IJzerman MJ, Manca A, Keizer J, Ramsey SD
Comparative Effectiveness Research 2015, 5:65-72
Published Date: 26 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Unannounced or announced periodic hospital surveys: a study protocol for a nationwide cluster-randomized controlled trial
Simonsen KB, Olesen AV, Jensen MB, Rasmussen GS, Ehlers LH
Comparative Effectiveness Research 2015, 5:57-63
Published Date: 1 September 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The role and importance of economic evaluation of traditional herbal medicine use for chronic non-communicable diseases
Hughes GD, Aboyade OM, Hill JD, Rasu RS
Comparative Effectiveness Research 2015, 5:49-55
Published Date: 16 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Hao Y, Meyer N, Landsman-Blumberg P, Johnson W, Willemann Rogerio J
Comparative Effectiveness Research 2015, 5:35-47
Published Date: 28 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Meyer N, Hao Y, Landsman-Blumberg P, Johnson W, Juneau P, Willemann Rogerio J
Comparative Effectiveness Research 2015, 5:21-34
Published Date: 28 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Defining the benefits and challenges of stakeholder engagement in systematic reviews
Cottrell EK, Whitlock EP, Kato E, Uhl S, Belinson S, Chang C, Hoomans T, Meltzer DO, Noorani H, Robinson KA, Motu’apuaka M, Anderson J, Paynter RA, Guise JM
Comparative Effectiveness Research 2015, 5:13-19
Published Date: 16 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of infliximab and ustekinumab for the treatment of moderate-to-severe psoriasis: an indirect comparison meta-analysis
Fan T, Bennett HA, Smith NE, Marin M, Sen SS
Comparative Effectiveness Research 2015, 5:1-11
Published Date: 23 March 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
When patient-centeredness and evidence-based medicine collide
Braithwaite RS
Comparative Effectiveness Research 2014, 4:29-32
Published Date: 5 July 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current issues in comparative effectiveness research for hepatitis C
Yoo M, Cheng Y, Rhien TJ, Biskupiak J
Comparative Effectiveness Research 2014, 4:13-27
Published Date: 26 June 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Challenges conducting comparative effectiveness research: the Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) experience
Friedly JL, Bauer Z, Comstock BA, DiMango E, Ferrara A, Huang SS, Israel E, Jarvik JG, Nierenberg AA, Ong MK, Penson DF, Smith-Bindman R, Stillman AE, Vollmer WM, Warren SM, Zhan C, Hsia DC, Trontell A
Comparative Effectiveness Research 2014, 4:1-12
Published Date: 3 May 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Interpreting the quality of health care database studies on the comparative effectiveness of oral anticoagulants in routine care
Schneeweiss S, Huybrechts KF, Gagne JJ
Comparative Effectiveness Research 2013, 3:33-41
Published Date: 9 September 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Using customer-focused research and design to build a self-service online store: a case study
Ahmadi MB, Trefzger W, Morey R, Quintas I
Comparative Effectiveness Research 2013, 3:21-32
Published Date: 5 February 2013
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A tool for assessing the feasibility of comparative effectiveness research
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/JdgUa7-Urfw/1.jpg)
Walker AM, Patrick AR, Lauer MS, Hornbrook MC, Marin MG, Platt R, Roger VL, Stang P, Schneeweiss S
Comparative Effectiveness Research 2013, 3:11-20
Published Date: 30 January 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states?
Crowley MJ, Powers BJ, Myers ER, McCrory DC, McBroom AJ, Sanders GD
Comparative Effectiveness Research 2013, 3:1-9
Published Date: 10 January 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparative effectiveness trial of family-supported smoking cessation intervention versus standard telephone counseling for chronically ill veterans using proactive recruitment
Bastian LA, Fish LJ, Gierisch JM, Rohrer LD, Stechuchak KM, Grambow SC
Comparative Effectiveness Research 2012, 2:45-56
Published Date: 27 September 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
International survey of methods used in health technology assessment (HTA): does practice meet the principles proposed for good research?
Stephens JM, Handke B, Doshi JA
Comparative Effectiveness Research 2012, 2:29-44
Published Date: 31 August 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Monotherapy of androgen deprivation therapy versus radical prostatectomy among veterans with localized prostate cancer: comparative effectiveness analysis of retrospective cohorts
Liu J, Shi L, Sartor O
Comparative Effectiveness Research 2012, 2:21-27
Published Date: 1 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A more rapid approach to systematically assessing published associations of genetic polymorphisms and disease risk: type 2 diabetes as a test case
Cho AH, Jiang X, Mann DM, Kawamoto K, Robinson TJ, Wang N, McCarthy JJ, Woodward M, Ginsburg GS
Comparative Effectiveness Research 2012, 2:1-20
Published Date: 26 January 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Assessing exchangeability in indirect and mixed treatment comparisons
Alemayehu D
Comparative Effectiveness Research 2011, 1:51-55
Published Date: 20 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Telemedicine vs in-person cancer genetic counseling: measuring satisfaction and conducting economic analysis
Datta SK, Buchanan AH, Hollowell GP, Beresford HF, Marcom PK, Adams MB
Comparative Effectiveness Research 2011, 1:43-50
Published Date: 19 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Challenges and opportunities in comparative effectiveness research
Voils CI, Maciejewski ML
Comparative Effectiveness Research 2011, 1:39-41
Published Date: 19 April 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ultrasound-guided transversus abdominis plane blocks for analgesia post cesarean section
Kelly SMC, Malhotra RK
Comparative Effectiveness Research 2011, 1:35-38
Published Date: 14 April 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The effect of comparative effectiveness research on drug development innovation: a 360° value appraisal
Doyle JJ
Comparative Effectiveness Research 2011, 1:27-34
Published Date: 25 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies – an overview
Shaik Mastan, Thirunagari Bhavya Latha, Sathe Ajay
Comparative Effectiveness Research 2011, 1:1-25
Published Date: 22 March 2011